Prestige Consumer Healthcare Inc. Company Profile
NYSE: PBHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Prestige Consumer Healthcare at a glance
Prestige Consumer Healthcare Inc. (NYSE: PBH) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Tarrytown, NY. Prestige Consumer Healthcare is led by Mr. Ronald M. Lombardi CPA and employs about 890 people. The company's shares have traded publicly since 2005.
At a market capitalization of $2.27 billion, it is considered a mid-cap company. Its SEC Central Index Key (CIK) is 0001295947, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Prestige Consumer Healthcare do?
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Business description based on the company's public filings.
Company information
- Legal name
- Prestige Consumer Healthcare Inc.
- Ticker
- NYSE: PBH
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Ronald M. Lombardi CPA
- Employees
- 890
- Headquarters
- 660 White Plains Road, Tarrytown, NY, United States
- Phone
- 914 524 6800
- Website
- prestigebrands.com
- IPO year
- 2005
- Market cap
- $2.27B
- SEC CIK
- 0001295947
- Latest annual report
- 10-K · May 14, 2026
Companies similar to Prestige Consumer Healthcare
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BHCBausch Health Companies Inc. | 6.04 | 0.00% | $2.26B | vs PBH |
| IMNMImmunome Inc. | 19.55 | +1.24% | $2.31B | vs PBH |
| NRIXNurix Therapeutics Inc. | 22.35 | +0.63% | $2.32B | vs PBH |
| AUPHAurinia Pharmaceuticals Inc | 16.65 | +2.65% | $2.22B | vs PBH |
| HRMYHarmony Biosciences Holdings Inc. | 40.28 | +1.72% | $2.35B | vs PBH |
| SLSSELLAS Life Sciences Group Inc. | 11.65 | +3.46% | $2.35B | vs PBH |
| VERAVera Therapeutics Inc. Class A | 29.88 | +0.50% | $2.15B | vs PBH |
| IRONDisc Medicine Inc. | 62.06 | +2.12% | $2.38B | vs PBH |